ENTRY       D00891                      Drug
NAME        Abacavir sulfate (JAN/USP);
            Ziagen (TN)
PRODUCT     ZIAGEN (ViiV Healthcare Company)
  GENERIC   ABACAVIR (American Health Packaging)
            ABACAVIR (Aurobindo Pharma Limited)
            ABACAVIR (Aurobindo Pharma Limited)
            ABACAVIR (AvPAK)
            ABACAVIR (Camber Pharmaceuticals)
            ABACAVIR (Camber Pharmaceuticals)
            ABACAVIR (Cipla USA)
            ABACAVIR (Major Pharmaceuticals)
            ABACAVIR (REMEDYREPACK)
            ABACAVIR (Rising Pharmaceuticals)
            ABACAVIR (Strides Pharma Science Limited)
            ABACAVIR (XLCare Pharmaceuticals)
            ABACAVIR SULFATE (Mylan Institutional)
            ABACAVIR SULFATE (Mylan Pharmaceuticals)
FORMULA     (C14H18N6O)2. H2SO4
EXACT_MASS  670.2758
MOL_WEIGHT  670.7431
CLASS       Antiviral
             DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
             DG03107  Anti-HIV agent
              DG01656  HIV reverse transcriptase inhibitor
REMARK      Therapeutic category: 6250
            ATC code: J05AF06
            Chemical structure group: DG00660
            Product (DG00660): D00891<JP/US>
            Product (mixture): D08775<JP/US> D10600<JP/US> D10838<US>
EFFICACY    Antiviral, Reverse transcriptase inhibitor
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
INTERACTION  
STR_MAP     map07044  Antiviral agents
            map07053  Anti-HIV agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
                 J05AF06 Abacavir
                  D00891  Abacavir sulfate (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)
               Abacavir
                D00891  Abacavir sulfate (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D00891  Abacavir sulfate (JAN/USP)
            Drug groups [BR:br08330]
             Antiviral
              DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
               DG00660  Abacavir
                D00891  Abacavir sulfate
              DG03107  Anti-HIV agent
               DG01656  HIV reverse transcriptase inhibitor
                DG00660  Abacavir
                 D00891  Abacavir sulfate
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D00891  Abacavir sulfate
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D00891  Abacavir sulfate (JAN/USP) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00891
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00891
            Drug groups [BR:br08330]
             Antiviral
              DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
               DG00660  Abacavir
              DG03107  Anti-HIV agent
               DG01656  HIV reverse transcriptase inhibitor
                DG00660  Abacavir
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                DG00660  Abacavir
DBLINKS     CAS: 188062-50-2
            PubChem: 7847955
            ChEBI: 2361
            LigandBox: D00891
            NIKKAJI: J2.208.842D
ATOM        47
            1   S4a S    33.1161  -16.8714
            2   O1d O    31.7182  -16.8656
            3   O1d O    34.5138  -16.8714
            4   O1d O    33.1102  -15.4737
            5   O1d O    33.1102  -18.2750
            6   C8y C    23.3800  -16.8700
            7   C8y C    23.3800  -18.3400
            8   C8y C    24.5700  -16.1700
            9   N5x N    22.1900  -16.3800
            10  N4y N    22.1200  -18.7600
            11  N5x N    24.5700  -19.1100
            12  N1b N    24.5700  -14.8400
            13  N5x N    25.8300  -16.9400
            14  C8x C    21.3500  -17.5000
            15  C1y C    21.0000  -19.6700
            16  C8y C    25.8300  -18.4100
            17  C1y C    25.8300  -14.1400
            18  C1x C    19.8100  -18.9000
            19  C2x C    20.5800  -21.0000
            20  N1a N    27.0200  -19.1800
            21  C1x C    27.2300  -14.2100
            22  C1x C    26.5300  -12.9500
            23  C1y C    18.7600  -19.6700
            24  C2x C    19.2500  -21.0000
            25  C1b C    17.4300  -19.3200
            26  O1a O    16.3800  -20.1600
            27  C8y C    23.3800  -16.8700
            28  C8y C    23.3800  -18.3400
            29  N4y N    22.1200  -18.7600
            30  C1y C    21.0000  -19.6700
            31  C1x C    19.8100  -18.9000
            32  C1y C    18.7600  -19.6700
            33  C1b C    17.4300  -19.3200
            34  O1a O    16.3800  -20.1600
            35  C2x C    19.2500  -21.0000
            36  C2x C    20.5800  -21.0000
            37  C8x C    21.3500  -17.5000
            38  N5x N    22.1900  -16.3800
            39  N5x N    24.5700  -19.1100
            40  C8y C    25.8300  -18.4100
            41  N1a N    27.0200  -19.1800
            42  N5x N    25.8300  -16.9400
            43  C8y C    24.5700  -16.1700
            44  N1b N    24.5700  -14.8400
            45  C1y C    25.8300  -14.1400
            46  C1x C    27.2300  -14.2100
            47  C1x C    26.5300  -12.9500
BOND        52
            1     1   2 1
            2     1   3 1
            3     1   4 2
            4     1   5 2
            5     6   7 2
            6     6   8 1
            7     6   9 1
            8     7  10 1
            9     7  11 1
            10    8  12 1
            11    8  13 2
            12    9  14 2
            13   15  10 1 #Up
            14   11  16 2
            15   12  17 1
            16   15  18 1
            17   15  19 1
            18   16  20 1
            19   17  21 1
            20   17  22 1
            21   18  23 1
            22   19  24 2
            23   23  25 1 #Up
            24   25  26 1
            25   10  14 1
            26   13  16 1
            27   21  22 1
            28   23  24 1
            29   27  28 2
            30   27  43 1
            31   27  38 1
            32   28  29 1
            33   28  39 1
            34   43  44 1
            35   43  42 2
            36   38  37 2
            37   30  29 1 #Up
            38   39  40 2
            39   44  45 1
            40   30  31 1
            41   30  36 1
            42   40  41 1
            43   45  46 1
            44   45  47 1
            45   31  32 1
            46   36  35 2
            47   32  33 1 #Up
            48   33  34 1
            49   29  37 1
            50   42  40 1
            51   46  47 1
            52   32  35 1
BRACKET     1    13.6500  -20.7200   13.6500  -13.1600
            1    29.4000  -13.1600   29.4000  -20.7200
            1  2
  ORIGINAL  1    6   7  10  15  18  23  25  26  24  19  14   9  11  16  20  13
            1    8  12  17  21  22
  REPEAT    1   27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42
            1   43  44  45  46  47
///
